These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33740987)

  • 1. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy.
    Fairley LH; Sahara N; Aoki I; Ji B; Suhara T; Higuchi M; Barron AM
    J Neuroinflammation; 2021 Mar; 18(1):76. PubMed ID: 33740987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
    Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
    J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
    Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M
    J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases.
    Biechele G; Franzmeier N; Blume T; Ewers M; Luque JM; Eckenweber F; Sacher C; Beyer L; Ruch-Rubinstein F; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Cumming P; Bartenstein P; Rominger A; Höglinger GU; Herms J; Brendel M
    J Neuroinflammation; 2020 Dec; 17(1):374. PubMed ID: 33317543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
    Endepols H; Anglada-Huguet M; Mandelkow E; Schmidt Y; Krapf P; Zlatopolskiy BD; Neumaier B; Mandelkow EM; Drzezga A
    Mol Neurobiol; 2022 Jun; 59(6):3402-3413. PubMed ID: 35312967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
    Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
    J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning.
    Eckenweber F; Medina-Luque J; Blume T; Sacher C; Biechele G; Wind K; Deussing M; Briel N; Lindner S; Boening G; von Ungern-Sternberg B; Unterrainer M; Albert NL; Zwergal A; Levin J; Bartenstein P; Cumming P; Rominger A; Höglinger GU; Herms J; Brendel M
    J Neuroinflammation; 2020 Jul; 17(1):208. PubMed ID: 32660586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions.
    Fairley LH; Lai KO; Grimm A; Eckert A; Barron AM
    Biochimie; 2024 Sep; 224():120-131. PubMed ID: 38971458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy.
    Sahara N; Maeda J; Ishikawa A; Tokunaga M; Suhara T; Higuchi M
    J Alzheimers Dis; 2018; 64(s1):S353-S359. PubMed ID: 29865054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy.
    Barron AM; Ji B; Fujinaga M; Zhang MR; Suhara T; Sahara N; Aoki I; Tsukada H; Higuchi M
    Neurobiol Aging; 2020 Oct; 94():140-148. PubMed ID: 32623260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.
    Dejanovic B; Huntley MA; De Mazière A; Meilandt WJ; Wu T; Srinivasan K; Jiang Z; Gandham V; Friedman BA; Ngu H; Foreman O; Carano RAD; Chih B; Klumperman J; Bakalarski C; Hanson JE; Sheng M
    Neuron; 2018 Dec; 100(6):1322-1336.e7. PubMed ID: 30392797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies.
    Grimm A; Lejri I; Hallé F; Schmitt M; Götz J; Bihel F; Eckert A
    J Neuroendocrinol; 2020 Jan; 32(1):e12796. PubMed ID: 31536662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
    Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK-8719, a Novel and Selective
    Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
    J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease.
    Barron AM; Garcia-Segura LM; Caruso D; Jayaraman A; Lee JW; Melcangi RC; Pike CJ
    J Neurosci; 2013 May; 33(20):8891-7. PubMed ID: 23678130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.